Your shopping cart is currently empty

CCG258208 hydrochloride (compound 14as hydrochloride) is a highly potent and selective G protein-coupled receptor kinase 2 (GRK2) inhibitor with an IC50 of 30 nM. It exhibits >200-fold selectivity for GRK2 over GRK5 (IC50 = 7.1μM). In cardiovascular research, CCG258208 effectively enhances the contractility of beta-AR-stimulated cardiomyocytes by inhibiting GRK2 activity. Additionally, the compound demonstrates excellent in vivo stability, making it a valuable tool for studying GRK2-related conditions such as heart failure.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $117 | - | In Stock | |
| 5 mg | Preferential | - | In Stock |
| Description | CCG258208 hydrochloride (compound 14as hydrochloride) is a highly potent and selective G protein-coupled receptor kinase 2 (GRK2) inhibitor with an IC50 of 30 nM. It exhibits >200-fold selectivity for GRK2 over GRK5 (IC50 = 7.1μM). In cardiovascular research, CCG258208 effectively enhances the contractility of beta-AR-stimulated cardiomyocytes by inhibiting GRK2 activity. Additionally, the compound demonstrates excellent in vivo stability, making it a valuable tool for studying GRK2-related conditions such as heart failure. |
| Targets&IC50 | GRK2:30 nM, GRK5:7.1 uM |
| In vitro | CCG258208 hydrochloride potently inhibits GRK2 (IC50=30 nM) with minimal activity against GRK5. In mouse cardiomyocytes, it (0.1-1 μM, 10 min) significantly enhances β-AR-stimulated contractility, with effects observed at concentrations as low as 0.1 μM [1]. |
| In vivo | In pharmacological studies using CD-1 mice, a single intraperitoneal (IP) injection of CCG258208 hydrochloride (10 mg/kg) demonstrates favorable pharmacokinetic properties. The treatment maintains total plasma drug levels that exceed the GRK2 IC50 for approximately seven hours [1]. |
| Synonyms | GRK2-IN-1 hydrochloride |
| Molecular Weight | 488.94 |
| Formula | C24H26ClFN4O4 |
| Smiles | FC(C=C1)=C(C(NCC2=CC=NN2)=O)C=C1[C@H]3[C@H](COC4=CC5=C(OCO5)C=C4)CNCC3.Cl |
| Storage | keep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 40.00 mg/mL (81.81 mM), Sonication is recommended. DMSO: 200.00 mg/mL (409.05 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.40 mg/mL (4.91 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.